- $101.58bn
- $97.48bn
- $7.06bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 40-F | 40-F | 40-F | 40-F | 40-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,578 | 2,929 | 4,612 | 5,600 | 7,060 |
Cost of Revenue | |||||
Gross Profit | 866 | 1,542 | 2,481 | 2,754 | 3,515 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,719 | 2,839 | 4,343 | 6,422 | 8,478 |
Operating Profit | -141 | 90.2 | 269 | -822 | -1,418 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -95.8 | 240 | 3,141 | -3,623 | 185 |
Provision for Income Taxes | |||||
Net Income After Taxes | -125 | 320 | 2,915 | -3,460 | 132 |
Net Income Before Extraordinary Items | |||||
Net Income | -125 | 320 | 2,915 | -3,460 | 132 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -125 | 320 | 2,915 | -3,460 | 133 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.11 | 0.289 | 2.31 | -2.64 | 0.887 |